SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-046288
Filing Date
2014-07-07
Accepted
2014-07-07 20:49:35
Documents
1
Period of Report
2014-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9165
  Complete submission text file 0001209191-14-046288.txt   11761
Mailing Address 909 THIRD AVENUE NEW YORK NY 10022
Business Address 909 THIRD AVENUE NEW YORK NY 10022 (212)421-7850
Forest Laboratories, LLC (Reporting) CIK: 0000038074 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0913
Type: 4 | Act: 34 | File No.: 001-34641 | Film No.: 14964004
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Issuer) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2
Business Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2 (216) 523-5000
Actavis plc (Reporting) CIK: 0001578845 (see all company filings)

State of Incorp.: L2 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34641 | Film No.: 14964003
SIC: 2834 Pharmaceutical Preparations